INTRODUCTION
Pathologic ketosis is unusual in the newborn infant. In addition to diabetes mellitus and type I glycogen storage disease, several other metabolic abnormalities have been associated with ketosis in the neonate. These include defects in organic acid metabolism, such as ketotic hyperglycinemia (1, 2) and methylmalonic acidemia (3, 4) as well as in gluconeogenesis such as fructose-1,6-diphosphatase deficiency (5) . Intermittent and mild ketonuria has been observed with lactic acid acidosis (6) , and salicylate intoxication (7) .
The mechanisms which are responsible for the increase in plasma and urine ketone bodies (i.e., P-hydroxybutyrate and acetoacetate) in these diseases have remained obscure. Possible explanations include an increased production, an under utilization, and an alteration of a specific regulatory process in ketone metabolism.
The recent demonstration of the metabolic pathway for ketone body oxidation by peripheral tissue provides evidence for the role of these substrates in mammalian metabolism (8, 9) . In studies by Melichar, Drahota, and Hahn (10) and Persson and Gentz (11) it has been demonstrated that newborn infants have a four to sixfold increase in the level of plasma ketones the first days after birth. In rats, a similar increase in plasma ketone bodies has been correlated with an increase in ketone utilization by brain (12) (13) (14) . Studies in this laboratory (8) , by Klee and Sokoloff (13) and by Page, Krebs, and Williamson (15) have demonstrated that the increased utilization of these substrates resulted from the adaptive enzyme changes of P-hydroxybutyrate dehydrogenase and succinyl-CoA 3-ketoacid CoA-transferase activity during this period.
A unique opportunity to study these processes in the human was provided by a newborn infant who presented to the University of Maryland Hospital with persistent ketonemia and intermittent episodes of severe ketoacidosis. A detailed report of the clinical findings and laboratory data (16) indicated that he did not have any of the previously described causes of pathological ketosis. The episodes of severe ketoacidosis were precipitated by either an acute infection or by the administration of protein. Intensive therapy for 72-96 hr with parenteral glucose and alkali were necessary before he recovered from his ketoacidotic episodes. However, when glucose was the sole source of calories, the infant did well and had minimal ketonuria.
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The pattern of abnormal homeostasis in the presence of protein and the restoration to normal metabolism with glucose, as the only exogenous metabolite, appeared to be correlated with an abnormal metabolic process observed in the tissue culture fibroblasts derived from a skin biopsy from this infant (17) . The results of that study demonstrated a striking reduction in glycolysis by the patient's fibroblasts. Additional experiments have indicated that the abnormal metabolism in these cells resulted from a possible metabolic inhibitor which accumulated in the presence of total media (i.e., protein and amino acids)-but became normal after incubation for 12-18 hr in the presence of glucose alone (18) .
It is the purpose of this report to describe a deficiency in succinyl-CoA: 3-ketoacid CoA-transferase (CoAtransferase) in the post mortem tissues and the cultured fibroblasts of this infant, and to suggest a relationship which correlates this deficiency with the observed clinical manifestations and the biochemical studies of his tissue culture fibroblasts.
METHODS
Case summary, C. C. (UM 37-83-57). Boy C was born on 8 March 1968 to a 16 yr old para 0000 Negro female whose past medical history was unremarkable. The 37 wk old pregnancy, labor, and delivery were uncomplicated. The father was 16 yr old and healthy and the parents were unrelated. Physical examination at 2i hr of age revealed that the infant weighed 7 lb. 4 oz (3289 g) and was 20i inches (52 cm) in length. The head circumference was 36 cm; the chest circumference was 33 cm. He was given routine care in the full-term nursery. On the 2nd day of life he developed tachypnea that persisted throughout his nursery course, however, all known causes of tachypnea were excluded, but a urinalysis for ketones was not done.
The patient was fully digitalized (50 ,ug/kg) during the initial week of life and maintained on digitalis for 20 days without effect on the tachypnea or tachycardia. He gradually improved, took his formula well, was alert, and except for rapid and unlabored respiration appeared normal. On the 40th day of life he was discharged weighing 4.55 kg with a length of 53.5 cm.
The patient was readmitted at 51 days of age after an acute illness associated with anorexia of 18 hr duration. He had a severe metabolic acidosis (pH = 6.93) with a strongly positive urine and serum acetone. Intensive parenteral fluids and alkali therapy, including sodium bicarbonate, tham, and glucose were necessary for 4 days before his pH was within normal limits. The episode of severe ketotic acidosis was one of six that occurred throughout his life. During each episode, the glucose and hemograms were normal. Variable increases in plasma values for glycine, proline, lysine, and uric acid were observed. Plasma values for immunoreactive insulin were consistently decreased (< 10 uU/ml) ; free fatty acids (FFA) consistently elevated (1.4 mEq/liter) ; and blood glucose normal (60-90 mg/100 ml) when he was acidotic or euacidemic. The ketotic episodes followed acute infections, mild dehydration, and on two occasions after the administration of protein, once after intravenous plasma and the other after 1.5 g/kg of soya bean protein. Each episode lasted 72-96 hr and required parenteral fluids. From the 20th wk to the 23rd wk of life, he was given only glucose water by mouth during which period his urinary ketones remained low.
At 24 wk of age, respiratory arrest occurred independent of the ketoacidosis. The patient required mechanical ventilation. 2 wk later a superimposed infection occurred which resulted in death at 61 months of age. A post mortem examination was essentially unrevealing except for an extensive pneumonia and fatty infiltration of the liver. It was noted that the brain size was reduced. Tissue samples were obtained within 2 hr after death and frozen at -60'C for subsequent biochemical studies.
Enzyme assays. CoA-transferase catalyzes the stoichiometric and reversible transfer of CoA from succinyl-CoA to a 3-ketoacid. The assay procedure represents a modification (8) of the method described by Hersh and Jencks (19) . Post mortem tissue and fibroblasts were homogenized in 0.3% deoxycholate in 0.25 M sucrose solution, or in water. The water homogenate was frozen and thawed three times.
The assay procedure measured the reduction in absorption at 313 nm of the enolate form of the acetoacetyl-CoA derivative in the presence of MgCl2 at pH 8.4 (20) . f-Hydroxybutyrate dehydrogenase activity was determined by the method of Lehninger, Sudduth, and Wise (21) .
The methods used for the assays of glycolytic enzymes which included triose phosphate dehydrogenase, enolase, phosphoglycerate kinase, pyruvate kinase, and phosphofructokinase were standard assay procedures as described in reference 22. Protein determinations were made either by the method of Lowry, Rosebrough, Farr, and Randall (23) or by ultraviolet absorption (24) .
Tissue culture technique. Skin fibroblasts were grown from a punch biopsy specimen obtained 5 wk before the death of the patient. Control strains were derived from the foreskin of four normal males. The fibroblasts were maintained in Eagle's minimal media containing 10% fetal calf serum with added glutamine, penicillin, and streptomycin (17) . Tests 23 days, and 4* months, whose causes of death were not associated with ketoacidosis. CoA-transferase activity was highest in the brain with decreasing values in the kidney and muscle tissues. In contrast, no CoA-transferase activity was present in any of the tissues from patient C (Table I) . Increasing the amount of homogenate protein in the reaction mixture to more than five times the concentration used for controls, still failed to reveal any CoAtransferase activity. Additional results also showed that the absence of CoA-transferase was not an artifact of tissue storage. Post mortem control tissue which was kept at room temperature for 36 hr still contained measurable amounts of CoA-transferase activity and tissue stored for more than 7 months at -600C did not lose any appreciable enzyme activity. Several mixing experiments using the addition of active enzyme either from control homogenate (Table II) or purified CoA-transferase activity showed no evidence of either an inhibitor or an activator.
Using the same homogenate preparations, assays were made for thiolase activity in post mortem tissues from the patient and controls. In all of the patient's tissues examined, there were measurable amounts of thiolase activity (Table I) . The values varied somewhat from those of the control tissues with the patient's brain homogenate having considerably less and his kidney homogenate somewhat higher activity than those of controls. Although there was considerable experimental difficulty in the measurement of P-hydroxybutyrate dehydrogenase in frozen post mortem tissue, the activity of this enzyme in the frozen post mortem liver sample from the patient was comparable with the activity of two control samples (0.79 vs. 0.50 and 1.12 nmoles/min per mg mitochondrial protein). (Table III) . Using comparable protein concentrations in the reaction mixture, no measurable amounts of CoA-transferase could be demonstrated in the skin fibroblasts from the patient. In contrast, assays for both thiolase activity and triose phosphate dehydrogenate activity in these same homogenates gave similar results in cells from both the patient and the control (Table III) .
Glycolytic enzymes. Assays for six glycolytic enzymes were made on the homogenates of post mortem tissue and for five enzymes in the homogenate of the tissue culture fibroblasts. In the fibroblasts from patient C, the activities for all of the enzymes measured were 40-130% those of control values (Fig. 1) . The enzyme activities found in the post mortem tissue were consistently less than those of the controls (18-75%). However, there was no correlation between the amount of a specific enzyme activity found in the tissue culture cells compared with that in the post mortem tissue. An (12) (13) (14) . Although the exact metabolic pathway for ketone utilization by the peripheral tissue of the newborn infant is yet to be defined, the evidence would suggest that for most tissues, ketone oxidation involves the conversion of 8-hydroxybutyrate to acetoacetate. The acid is then activated to acetoacetyl-CoA followed by its clevage to two molecules of acetyl-CoA. This metabolic pathway and the enzyme for each step is outlined in Fig. 2 A similar conclusion might also be appropriate for the reduced activities obtained for glycolytic enzymes. However, it has been reported that prolonged malnutrition causes a reduction in the specific activities of several glycolytic enzymes (26) . It therefore seems reasonable to infer that these diminished enzyme activities were related to the reduced nutritional intake of this infant during the last month of his life rather than to his ketoacidosis. The terminal malnutrition of this infant might also explain the increased inhibitory effect of phenylalanine on the muscle pyruvate kinase of this infant since similar effects by both competitive and noncompetitive inhibitors on this enzyme have been observed by Metcoff (26) . In contrast, it has been demonstrated that extended starvation does not affect CoA-transferase in rats (8, 9) . Therefore, the absence of this enzyme activity was probably not the result of malnutrition.
The reversible transfer of CoA from succinate to acetoacetate by CoA-transferase, places this enzyme in a pivotal position in any interrelationship between carbohydrate metabolism and the oxidation of ketone bodies. Substrate oxidation studies of the patient's fibroblasts that contained no CoA-transferase activity, revealed a striking reduction of glucose utilization as compared with that by fibroblasts from normal controls (17, 18) . This difference was the result of a diminished oxidation via the Embden-Myerhoff pathway. Measurements of enzyme activities demonstrate that this transient reduction in glucose utilization was probably not due to the absence of any of the glycolytic enzymes. Instead, the results suggest that the diminished glycolysis might have resulted from the presence of an endogenous inhibitor. It seems reasonable to infer that this inhibitor could have accumulated as the direct consequence of the absence of CoA transferase activity.
If the altered glycolysis in these fibroblasts is indicative of the metabolism by the other peripheral tissue of this patient, it can be inferred that this would cause an additional imbalance in an already disturbed homeostasis. Thus, an intermittent, severe ketoacidosis would be coincident with an increased protein catabolism after infection or starvation or with elevated serum amino acids after protein administration.
The factors which contribute to neonatal ketoacidosis are varied. Several metabolic errors such as methylmalonic aciduria and hyperglycinemia have been associated with increased ketosis, the mechanism of which remains obscure. It should be noted, however, that these metabolic errors seemed to be associated with enzyme deficiencies that result in an alteration of the intracellular concentration of succinyl-CoA. CoA-transferase deficiency as described above would also affect the intracellular concentration of succinyl-CoA. These results indicate that the possible interrelationship between altered succinyl-CoA concentrations and ketoacidosis requires further investigation.
The differential diagnosis of pathological ketosis in the neonate must include CoA-transferase deficiency. Because of the selective distribution of the enzyme and its absence in erythrocytes and leukocytes, the diagnosis in living patients would require a skin biopsy with serial propagation of fibroblasts in tissue culture in order to assay for the presence of CoA-transferase activity. Additional confirmation of the diagnosis would be the reversible diminished glycolysis in these fibroblasts (17) .
